Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010402 |
---|---|
Receipt number | R000012165 |
Scientific Title | Phase II study of S-1 alternate-day and bevacizumab in elderly patients with advanced colorectal cancer |
Date of disclosure of the study information | 2013/04/02 |
Last modified on | 2018/10/09 07:47:28 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/04/02 19:10:22 | ||
2 | Update | 2015/10/02 12:49:31 | Last follow-up date |
|
3 | Update | 2017/01/02 12:00:51 | Recruitment status |
|
4 | Update | 2017/10/05 09:45:13 | Division name Division name Address Address TEL Division name Division name Address Address TEL Name of primary person or sponsor Organization |
|
5 | Update | 2018/10/09 07:47:29 | Recruitment status Last follow-up date Date trial data considered complete Date analysis concluded Publication of results Results |